10 Patents
- US125903052026Complement Component C5 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US124924012025Angiopoietin-like 3 (ANGPTL3) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - 0 cites
- US123384392025Factor XII (hageman Factor) (F12), Kallikrein B, Plasma (fletcher Factor) 1 (KLKB1), and Kininogen 1 (KNG1) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US121732892024Hepatitis B Virus (HBV) Dsrna Agent Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - 0 cites
- US120496282024Transthyretin (TTR) Irna Compositions and Methods of Use Thereof for Treating or Preventing Ttr-associated Diseases
Alnylam Pharmaceuticals, Inc.
0 cites - US118734912024Complement Component C5 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - 0 cites
- 0 cites